The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment

Hepatocellular carcinoma (HCC) is one of most common cancers and the fourth leading cause of death worldwide. Commonly, HCC development occurs in a liver that is severely compromised by chronic injury or inflammation. Liver transplantation, hepatic resection, radiofrequency ablation (RFA), transcath...

Full description

Bibliographic Details
Main Authors: Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
hepatocellular carcinoma
immune checkpoint molecules
immune checkpoint inhibitors
immune microenvironment
Online Access:https://www.mdpi.com/2076-393X/9/5/532

Similar Items

Similar Items